Untersuchungen zur Wirkung von Hypoxie auf bioenergetisch relevante Funktionen von stimulierten CD4⁺-ZellenRené Dziurla111.121.2605#8531.3451.3.161.41.4.171.4.21.4.31.4.481.4.51.4.691.4.71.4.8102102.1112.212544#6213259#172223#1732.31415162.42.5172.62.6.11819605#33520605#138212.6.22223605#1662.72425605#16626605#1383273.1433#25528529#24229339#3253.230490#242313.332551#2563.433243#195243#2293435217#2953.53637272#225325#22538339#225328#22539344#225327#22540373#22541333#44605#1834243604#18844347#279352#27945279#6146367#214371#2143.647301#30248291#30249313#271314#27150132#4051303#271256#23152404#293404#334605#6613.7533.7.1543.7.25556456574.14.1.15859604.1.2616263646566674.1.3686970714.1.472734.1.574754.24.2.1767778604#974.2.27980605#1048182834.384858687885886. LiteraturverzeichnisEidesstattliche ErklärungAbkürzungsverzeichnisdeInhaltsverzeichnisHilfe 6. Literaturverzeichnis 1. Romagnani, S. (2004) Immunologic influences on allergy and the TH1/TH2 balance. J Allergy Clin Immunol 113, 395-400 2. Kuby, J. (1997) Immunology, Freeman,

New York

3. Dombrowski, K. E., Cone, J. C., Bjorndahl, J. M., and Phillips, C. A. (1995) Irreversible inhibition of human natural killer cell natural cytotoxicity by modification of the extracellular membrane by the adenine nucleotide analog 5'-p-(fluorosulfonyl)benzoyl adenosine. Cell Immunol 160, 199-204 4. Langston, H. P., Ke, Y., Gewirtz, A. T., Dombrowski, K. E., and Kapp, J. A. (2003) Secretion of IL-2 and IFN-gamma, but not IL-4, by antigen-specific T cells requires extracellular ATP. J Immunol 170, 2962-2970 5. Garber, K. (2004) Energy boost: the Warburg effect returns in a new theory of cancer. J Natl Cancer Inst 96, 1805-1806 6. Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., and Semenza, G. L. (1998) Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 12, 149-162 7. Mor, F., Quintana, F. J., and Cohen, I. R. (2004) Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization. J Immunol 172, 4618-4623 8. Rolfs, A., Kvietikova, I., Gassmann, M., and Wenger, R. H. (1997) Oxygen-regulated transferrin expression is mediated by hypoxia-inducible factor-1. J Biol Chem 272, 20055-20062 9. Lok, C. N., and Ponka, P. (1999) Identification of a hypoxia response element in the transferrin receptor gene. J Biol Chem 274, 24147-24152 10. Mukhopadhyay, C. K., Mazumder, B., and Fox, P. L. (2000) Role of hypoxia-inducible factor-1 in transcriptional activation of ceruloplasmin by iron deficiency. J Biol Chem 275, 21048-21054 11. Takahashi, Y., Takahashi, S., Shiga, Y., Yoshimi, T., and Miura, T. (2000) Hypoxic induction of prolyl 4-hydroxylase alpha (I) in cultured cells. J Biol Chem 275, 14139-14146 12. Wykoff, C. C., Pugh, C. W., Maxwell, P. H., Harris, A. L., and Ratcliffe, P. J. (2000) Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling. Oncogene 19, 6297-6305 13. Semenza, G. L., Roth, P. H., Fang, H. M., and Wang, G. L. (1994) Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 269, 23757-23763 14. Bruick, R. K., and McKnight, S. L. (2001) A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294, 1337-1340 15. Hellwig-Burgel, T., Rutkowski, K., Metzen, E., Fandrey, J., and Jelkmann, W. (1999) Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1. Blood 94, 1561-1567 16. Giatromanolaki, A., Sivridis, E., Maltezos, E., Athanassou, N., Papazoglou, D., Gatter, K. C., Harris, A. L., and Koukourakis, M. I. (2003) Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritis. Arthritis Res Ther 5, R193-201 17. Zhou, J., Schmid, T., and Brune, B. (2003) Tumor necrosis factor-alpha causes accumulation of a ubiquitinated form of hypoxia inducible factor-1alpha through a nuclear factor-kappaB-dependent pathway. Mol Biol Cell 14, 2216-2225 18. Giatromanolaki, A., Sivridis, E., Athanassou, N., Zois, E., Thorpe, P. E., Brekken, R. A., Gatter, K. C., Harris, A. L., Koukourakis, I. M., and Koukourakis, M. I. (2001) The angiogenic pathway "vascular endothelial growth factor/flk-1(KDR)-receptor" in rheumatoid arthritis and osteoarthritis. J Pathol 194, 101-108 19. Paleolog, E. M., Young, S., Stark, A. C., McCloskey, R. V., Feldmann, M., and Maini, R. N. (1998) Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis. Arthritis Rheum 41, 1258-1265 20. Burger, D. (2000) Cell contact-mediated signaling of monocytes by stimulated T cells: a major pathway for cytokine induction. Eur Cytokine Netw 11, 346-353 21. Houssiau, F. A., Coulie, P. G., and Van Snick, J. (1989) Distinct roles of IL-1 and IL-6 in human T cell activation. J Immunol 143, 2520-2524 22. Kuhweide, R., Van Damme, J., Lorre, K., Baroja, M. L., Tsudo, M., and Ceuppens, J. L. (1990) Accessory cell-derived helper signals in human T-cell activation with phytohemagglutinin: induction of interleukin 2-responsiveness by interleukin 6, and production of interleukin 2 by interleukin 1 [corrected]. Cytokine 2, 45-54 23. Tosato, G., and Jones, K. D. (1990) Interleukin-1 induces interleukin-6 production in peripheral blood monocytes. Blood 75, 1305-1310 24. Haddad, J. J. (2002) Recombinant human interleukin (IL)-1 beta-mediated regulation of hypoxia-inducible factor-1 alpha (HIF-1 alpha) stabilization, nuclear translocation and activation requires an antioxidant/reactive oxygen species (ROS)-sensitive mechanism. Eur Cytokine Netw 13, 250-260 25. Lowenthal, J. W., Zubler, R. H., Nabholz, M., and MacDonald, H. R. (1985) Similarities between interleukin-2 receptor number and affinity on activated B and T lymphocytes. Nature 315, 669-672 26. Seigel, L. J., Harper, M. E., Wong-Staal, F., Gallo, R. C., Nash, W. G., and O'Brien, S. J. (1984) Gene for T-cell growth factor: location on human chromosome 4q and feline chromosome B1. Science 223, 175-178 27. Weinberg, K., and Parkman, R. (1990) Severe combined immunodeficiency due to a specific defect in the production of interleukin-2. N Engl J Med 322, 1718-1723 28. Hollander, G. A., Zuklys, S., Morel, C., Mizoguchi, E., Mobisson, K., Simpson, S., Terhorst, C., Wishart, W., Golan, D. E., Bhan, A. K., and Burakoff, S. J. (1998) Monoallelic expression of the interleukin-2 locus. Science 279, 2118-2121 29. Bendiksen, S., and Rekvig, O. P. (2004) Interleukin-2, but not interleukin-15, is required to terminate experimentally induced clonal T-cell anergy. Scand J Immunol 60, 64-73 30. Houssiau, F., and Van Snick, J. (1992) IL6 and the T-cell response. Res Immunol 143, 740-743 31. Sutherland, G. R., Baker, E., Callen, D. F., Hyland, V. J., Wong, G., Clark, S., Jones, S. S., Eglinton, L. K., Shannon, M. F., Lopez, A. F., and et al. (1988) Interleukin 4 is at 5q31 and interleukin 6 is at 7p15. Hum Genet 79, 335-337 32. Fishman, D., Faulds, G., Jeffery, R., Mohamed-Ali, V., Yudkin, J. S., Humphries, S., and Woo, P. (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102, 1369-1376 33. Roodman, G. D., Kurihara, N., Ohsaki, Y., Kukita, A., Hosking, D., Demulder, A., Smith, J. F., and Singer, F. R. (1992) Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone. J Clin Invest 89, 46-52 34. Smyth, M. J., Zachariae, C. O., Norihisa, Y., Ortaldo, J. R., Hishinuma, A., and Matsushima, K. (1991) IL-8 gene expression and production in human peripheral blood lymphocyte subsets. J Immunol 146, 3815-3823 35. Schaerli, P., Britschgi, M., Keller, M., Steiner, U. C., Steinmann, L. S., Moser, B., and Pichler, W. J. (2004) Characterization of human T cells that regulate neutrophilic skin inflammation. J Immunol 173, 2151-2158 36. Kunz, M., Hartmann, A., Flory, E., Toksoy, A., Koczan, D., Thiesen, H. J., Mukaida, N., Neumann, M., Rapp, U. R., Brocker, E. B., and Gillitzer, R. (1999) Anoxia-induced up-regulation of interleukin-8 in human malignant melanoma. A potential mechanism for high tumor aggressiveness. Am J Pathol 155, 753-763 37. Mukaida, N., Harada, A., and Matsushima, K. (1998) Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions. Cytokine Growth Factor Rev 9, 9-23 38. de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., and de Vries, J. E. (1991) Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174, 1209-1220 39. Willems, F., Marchant, A., Delville, J. P., Gerard, C., Delvaux, A., Velu, T., de Boer, M., and Goldman, M. (1994) Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur J Immunol 24, 1007-1009 40. de Waal Malefyt, R., Yssel, H., and de Vries, J. E. (1993) Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol 150, 4754-4765 41. Groux, H., Bigler, M., de Vries, J. E., and Roncarolo, M. G. (1998) Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells. J Immunol 160, 3188-3193 42. Taga, K., Cherney, B., and Tosato, G. (1993) IL-10 inhibits apoptotic cell death in human T cells starved of IL-2. Int Immunol 5, 1599-1608 43. Eskdale, J., Kube, D., Tesch, H., and Gallagher, G. (1997) Mapping of the human IL10 gene and further characterization of the 5' flanking sequence. Immunogenetics 46, 120-128 44. Gibson, A. W., Edberg, J. C., Wu, J., Westendorp, R. G., Huizinga, T. W., and Kimberly, R. P. (2001) Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 166, 3915-3922 45. Asadullah, K., Eskdale, J., Wiese, A., Gallagher, G., Friedrich, M., and Sterry, W. (2001) Interleukin-10 promoter polymorphism in psoriasis. J Invest Dermatol 116, 975-978 46. Schotte, H., Schluter, B., Drynda, S., Willeke, P., Tidow, N., Assmann, G., Domschke, W., Kekow, J., and Gaubitz, M. (2004) Interleukin-10 promoter microsatellite polymorphisms are associated with response to long term treatment with etanercept in patients with rheumatoid arthritis. Ann Rheum Dis 47. Kokura, S., Wolf, R. E., Yoshikawa, T., Granger, D. N., and Aw, T. Y. (2000) T-lymphocyte-derived tumor necrosis factor exacerbates anoxia-reoxygenation-induced neutrophil-endothelial cell adhesion. Circ Res 86, 205-213 48. Dayer, J. M., Beutler, B., and Cerami, A. (1985) Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med 162, 2163-2168 49. Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., Nelson, N., Boiani, N., Schooley, K. A., Gerhart, M., Davis, R., Fitzner, J. N., Johnson, R. S., Paxton, R. J., March, C. J., and Cerretti, D. P. (1997) A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385, 729-733 50. Spies, T., Morton, C. C., Nedospasov, S. A., Fiers, W., Pious, D., and Strominger, J. L. (1986) Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complex. Proc Natl Acad Sci U S A 83, 8699-8702 51. Ragoussis, J., Bloemer, K., Weiss, E. H., and Ziegler, A. (1988) Localization of the genes for tumor necrosis factor and lymphotoxin between the HLA class I and III regions by field inversion gel electrophoresis. Immunogenetics 27, 66-69 52. Corrigall, V. M., Arastu, M., Khan, S., Shah, C., Fife, M., Smeets, T., Tak, P. P., and Panayi, G. S. (2001) Functional IL-2 receptor beta (CD122) and gamma (CD132) chains are expressed by fibroblast-like synoviocytes: activation by IL-2 stimulates monocyte chemoattractant protein-1 production. J Immunol 166, 4141-4147 53. Sanger, F., Nicklen, S., and Coulson, A. R. (1992) DNA sequencing with chain-terminating inhibitors. 1977. Biotechnology 24, 104-108 54. Caldwell, C. C., Kojima, H., Lukashev, D., Armstrong, J., Farber, M., Apasov, S. G., and Sitkovsky, M. V. (2001) Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions. J Immunol 167, 6140-6149 55. Hale, L. P., Braun, R. D., Gwinn, W. M., Greer, P. K., and Dewhirst, M. W. (2002) Hypoxia in the thymus: role of oxygen tension in thymocyte survival. Am J Physiol Heart Circ Physiol 282, H1467-1477 56. Lund-Olesen, K. (1970) Oxygen tension in synovial fluids. Arthritis Rheum 13, 769-776 57. Wallis, W. J., Simkin, P. A., and Nelp, W. B. (1985) Low synovial clearance of iodide provides evidence of hypoperfusion in chronic rheumatoid synovitis. Arthritis Rheum 28, 1096-1104 58. Romero-Alvira, D., and Roche, E. (1998) The keys of oxidative stress in acquired immune deficiency syndrome apoptosis. Med Hypotheses 51, 169-173 59. Long, A., Kelleher, D., Lynch, S., and Volkov, Y. (2001) Cutting edge: protein kinase C beta expression is critical for export of Il-2 from T cells. J Immunol 167, 636-640 60. Dreikhausen, U. E., Gorf, K., Resch, K., and Szamel, M. (2003) Protein kinase Cbeta1, a major regulator of TCR-CD28-activated signal transduction leading to IL-2 gene transcription and secretion. Int Immunol 15, 1089-1098 61. Foey, A. D., and Brennan, F. M. (2004) Conventional protein kinase C and atypical protein kinase Czeta differentially regulate macrophage production of tumour necrosis factor-alpha and interleukin-10. Immunology 112, 44-53 62. Na, Y. J., Jeon, Y. J., Suh, J. H., Kang, J. S., Yang, K. H., and Kim, H. M. (2001) Suppression of IL-8 gene expression by radicicol is mediated through the inhibition of ERK1/2 and p38 signaling and negative regulation of NF-kappaB and AP-1. Int Immunopharmacol 1, 1877-1887 63. Kim, H. Y., and Rikihisa, Y. (2002) Roles of p38 mitogen-activated protein kinase, NF-kappaB, and protein kinase C in proinflammatory cytokine mRNA expression by human peripheral blood leukocytes, monocytes, and neutrophils in response to Anaplasma phagocytophila. Infect Immun 70, 4132-4141 64. Krauss, S., Buttgereit, F., and Brand, M. D. (1999) Effects of the mitogen concanavalin A on pathways of thymocyte energy metabolism. Biochim Biophys Acta 1412, 129-138 65. Brand, K. A., and Hermfisse, U. (1997) Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species. Faseb J 11, 388-395 66. Naldini, A., and Carraro, F. (1999) Hypoxia modulates cyclin and cytokine expression and inhibits peripheral mononuclear cell proliferation. J Cell Physiol 181, 448-454 67. Wang, G. S., Qian, G. S., Mao, B. L., Cai, W. Q., Chen, W. Z., and Chen, Y. (2003) [Changes of interleukin-6 and Janus kinases in rats with hypoxic pulmonary hypertension]. Zhonghua Jie He He Hu Xi Za Zhi 26, 664-667 68. Rydberg, E. K., Salomonsson, L., Hulten, L. M., Noren, K., Bondjers, G., Wiklund, O., Bjornheden, T., and Ohlsson, B. G. (2003) Hypoxia increases 25-hydroxycholesterol-induced interleukin-8 protein secretion in human macrophages. Atherosclerosis 170, 245-252 69. Knoferl, M. W., Jarrar, D., Schwacha, M. G., Angele, M. K., Cioffi, W. G., Bland, K. I., and Chaudry, I. H. (2000) Severe hypoxemia in the absence of blood loss causes a gender dimorphic immune response. Am J Physiol Cell Physiol 279, C2004-2010 70. Kim, N. G., Lee, H., Son, E., Kwon, O. Y., Park, J. Y., Park, J. H., Cho, G. J., Choi, W. S., and Suk, K. (2003) Hypoxic induction of caspase-11/caspase-1/interleukin-1beta in brain microglia. Brain Res Mol Brain Res 114, 107-114 71. Bosco, M. C., Puppo, M., Pastorino, S., Mi, Z., Melillo, G., Massazza, S., Rapisarda, A., and Varesio, L. (2004) Hypoxia selectively inhibits monocyte chemoattractant protein-1 production by macrophages. J Immunol 172, 1681-1690 72. Safronova, O., Nakahama, K., Onodera, M., Muneta, T., and Morita, I. (2003) Effect of hypoxia on monocyte chemotactic protein-1 (MCP-1) gene expression induced by Interleukin-1beta in human synovial fibroblasts. Inflamm Res 52, 480-486 73. Jeong, H. J., Chung, H. S., Lee, B. R., Kim, S. J., Yoo, S. J., Hong, S. H., and Kim, H. M. (2003) Expression of proinflammatory cytokines via HIF-1alpha and NF-kappaB activation on desferrioxamine-stimulated HMC-1 cells. Biochem Biophys Res Commun 306, 805-811 74. Jung, Y. J., Isaacs, J. S., Lee, S., Trepel, J., and Neckers, L. (2003) IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. Faseb J 17, 2115-2117 75. Stiehl, D. P., Jelkmann, W., Wenger, R. H., and Hellwig-Burgel, T. (2002) Normoxic induction of the hypoxia-inducible factor 1alpha by insulin and interleukin-1beta involves the phosphatidylinositol 3-kinase pathway. FEBS Lett 512, 157-162 76. Williams, R. O., Marinova-Mutafchieva, L., Feldmann, M., and Maini, R. N. (2000) Evaluation of TNF-alpha and IL-1 blockade in collagen-induced arthritis and comparison with combined anti-TNF-alpha/anti-CD4 therapy. J Immunol 165, 7240-7245 77. Bresnihan, B., Alvaro-Gracia, J. M., Cobby, M., Doherty, M., Domljan, Z., Emery, P., Nuki, G., Pavelka, K., Rau, R., Rozman, B., Watt, I., Williams, B., Aitchison, R., McCabe, D., and Musikic, P. (1998) Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum 41, 2196-2204 78. Jeschke, M. G., Klein, D., Bolder, U., and Einspanier, R. (2004) Insulin attenuates the systemic inflammatory response in endotoxemic rats. Endocrinology 145, 4084-4093 79. Liese, A. M., Siddiqi, M. Q., Siegel, J. H., Deitch, E. A., and Spolarics, Z. (2002) Attenuated monocyte IL-10 production in glucose-6-phosphate dehydrogenase-deficient trauma patients. Shock 18, 18-23 80. Kuga, S., Otsuka, T., Niiro, H., Nunoi, H., Nemoto, Y., Nakano, T., Ogo, T., Umei, T., and Niho, Y. (1996) Suppression of superoxide anion production by interleukin-10 is accompanied by a downregulation of the genes for subunit proteins of NADPH oxidase. Exp Hematol 24, 151-157 81. Walmsley, S. R., Print, C., Farahi, N., Peyssonnaux, C., Johnson, R. S., Cramer, T., Sobolewski, A., Condliffe, A. M., Cowburn, A. S., Johnson, N., and Chilvers, E. R. (2005) Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity. J Exp Med 201, 105-115 82. Stefanelli, C., Bonavita, F., Stanic, I., Farruggia, G., Falcieri, E., Robuffo, I., Pignatti, C., Muscari, C., Rossoni, C., Guarnieri, C., and Caldarera, C. M. (1997) ATP depletion inhibits glucocorticoid-induced thymocyte apoptosis. Biochem J 322 ( Pt 3), 909-917 83. Hata, H., Sakaguchi, N., Yoshitomi, H., Iwakura, Y., Sekikawa, K., Azuma, Y., Kanai, C., Moriizumi, E., Nomura, T., Nakamura, T., and Sakaguchi, S. (2004) Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice. J Clin Invest 114, 582-588 84. Yasuda, S., Arii, S., Mori, A., Isobe, N., Yang, W., Oe, H., Fujimoto, A., Yonenaga, Y., Sakashita, H., and Imamura, M. (2004) Hexokinase II and VEGF expression in liver tumors: correlation with hypoxia-inducible factor 1 alpha and its significance. J Hepatol 40, 117-123 85. Winder, W. W., Holmes, B. F., Rubink, D. S., Jensen, E. B., Chen, M., and Holloszy, J. O. (2000) Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. J Appl Physiol 88, 2219-2226 86. Murakami, K., Kanno, H., Tancabelic, J., and Fujii, H. (2002) Gene expression and biological significance of hexokinase in erythroid cells. Acta Haematol 108, 204-209 87. Murakami, K., Kanno, H., Miwa, S., and Piomelli, S. (1999) Human HKR isozyme: organization of the hexokinase I gene, the erythroid-specific promoter, and transcription initiation site. Mol Genet Metab 67, 118-130 88. Ackerman, A. D., Fackler, J. C., Tuck-Muller, C. M., Tarpey, M. M., Freeman, B. A., and Rogers, M. C. (1988) Partial monosomy 21, diminished activity of superoxide dismutase, and pulmonary oxygen toxicity. N Engl J Med 318, 1666-1669 89. Liochev, S. I., and Fridovich, I. (2000) Copper- and zinc-containing superoxide dismutase can act as a superoxide reductase and a superoxide oxidase. J Biol Chem 275, 38482-38485 90. Yim, M. B., Chock, P. B., and Stadtman, E. R. (1993) Enzyme function of copper, zinc superoxide dismutase as a free radical generator. J Biol Chem 268, 4099-4105 91.Takamiya, R., Takahashi, M., Myint, T., Park, Y. S., Miyazawa, N., Endo, T., Fujiwara, N., Sakiyama, H., Misonou, Y., Miyamoto, Y., Fujii, J., and Taniguchi, N. (2003) Glycation proceeds faster in mutated Cu, Zn-superoxide dismutases related to familial amyotrophic lateral sclerosis. Faseb J 17, 938-940 92. Mekhail, K., Gunaratnam, L., Bonicalzi, M. E., and Lee, S. (2004) HIF activation by pH-dependent nucleolar sequestration of VHL. Nat Cell Biol 6, 642-647 93. Zhang, H. G., Hyde, K., Page, G. P., Brand, J. P., Zhou, J., Yu, S., Allison, D. B., Hsu, H. C., and Mountz, J. D. (2004) Novel tumor necrosis factor alpha-regulated genes in rheumatoid arthritis. Arthritis Rheum 50, 420-431 94. Cendoroglo, M., Sundaram, S., Jaber, B. L., and Pereira, B. J. (1998) Effect of glucose concentration, osmolality, and sterilization process of peritoneal dialysis fluids on cytokine production by peripheral blood mononuclear cells and polymorphonuclear cell functions in vitro. Am J Kidney Dis 31, 273-282